Telix Pharmaceuticals Limited (TLPPF)

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4,261	2,153	1,437	1,473	670	227
Market Cap Growth	-	49.87%	-2.48%	119.86%	195.68%	8.58%
Enterprise Value	4,192	2,083	1,366	1,460	620	198
PE Ratio	1275.00	618.46	-20.66	-27.39	-22.34	-12.17
PS Ratio	7.79	6.41	13.79	450.20	214.31	97.33
PB Ratio	35.20	21.64	26.88	1021.82	12.69	4.84
P/FCF Ratio	468.26	246.20	-27.63	-36.35	612.31	-14.25
P/OCF Ratio	126.59	134.94	-33.62	-37.17	511.72	-14.54
EV/Sales Ratio	7.67	6.20	13.11	446.22	198.13	85.15
EV/EBITDA Ratio	61.31	53.34	-23.55	-31.19	-22.14	-12.12
EV/EBIT Ratio	67.98	60.51	-22.17	-29.05	-19.83	-10.33
EV/FCF Ratio	460.65	238.12	-26.27	-36.03	566.08	-12.47
Debt / Equity Ratio	0.07	0.07	0.13	1.18	0.03	0.03
Debt / EBITDA Ratio	0.19	0.30	-0.12	-0.04	-0.05	-0.09
Debt / FCF Ratio	1.40	1.33	-0.13	-0.04	1.35	-0.09
Quick Ratio	1.37	1.24	1.82	1.09	4.53	5.33
Current Ratio	1.63	1.43	2.02	1.25	4.69	5.52
Asset Turnover	2.17	1.25	0.61	0.04	0.03	0.03
Interest Coverage	8.30	52.03	-14.37	-14.42	-39.80	-11.92
Return on Equity (ROE)	18.19%	3.50%	-130.09%	-3730.77%	-56.81%	-39.76%
Return on Assets (ROA)	7.66%	1.30%	-40.76%	-73.32%	-28.44%	-27.16%
Return on Capital (ROIC)	36.72%	52.27%	-101.94%	-1602.02%	-57.57%	-39.76%
Earnings Yield	0.52%	0.16%	-4.84%	-3.65%	-4.48%	-8.22%
FCF Yield	0.21%	0.41%	-3.62%	-2.75%	0.16%	-7.02%
Buyback Yield / Dilution	-4.41%	-4.21%	-10.08%	-9.69%	-10.21%	-15.49%
Total Shareholder Return	-4.41%	-4.21%	-10.08%	-9.69%	-10.21%	-15.49%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.